1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The association between aberrant salience and psychotic experiences in general population twins, and genetic vulnerability as a modifier

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Previous studies assessing the hypothesis that the construct of ‘aberrant salience’ is associated with psychosis and psychotic symptoms showed conflicting results. For this reason, the association between measures to index aberrant salience and subclinical psychotic symptoms in a general population sample was analysed. In addition, genetic vulnerability was added to the analysis as a modifier to test the hypothesis that modification by genetic vulnerability may explain variability in the results.

          Methods

          The TwinssCan project obtained data from general population twins (N = 887). CAPE (Community Assessment of Psychic Experience) scores were used to index psychotic experiences. Aberrant salience was assessed with white noise task and ambiguous situations task.

          Results

          Measures of aberrant salience were not associated with psychotic experiences, nor was there evidence for an interaction with genetic predisposition in this association (Z = 1.08, p = 0.282).

          Conclusions

          Various studies including the present could not replicate the association between aberrant salience and psychotic experiences in general population samples. The conflicting findings might be explained by moderation by genetic vulnerability, but results are inconsistent. If there was evidence for a main effect or interaction, this was in the positive symptom scale only. On the other hand, the association was more robust in so-called ‘ultra-high risk’ patients and first episode psychosis patients. Thus, this association may represent a state-dependent association, present only at the more severe end of the psychosis spectrum.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: found
          • Article: found

          Biological Insights From 108 Schizophrenia-Associated Genetic Loci

          Summary Schizophrenia is a highly heritable disorder. Genetic risk is conferred by a large number of alleles, including common alleles of small effect that might be detected by genome-wide association studies. Here, we report a multi-stage schizophrenia genome-wide association study of up to 36,989 cases and 113,075 controls. We identify 128 independent associations spanning 108 conservatively defined loci that meet genome-wide significance, 83 of which have not been previously reported. Associations were enriched among genes expressed in brain providing biological plausibility for the findings. Many findings have the potential to provide entirely novel insights into aetiology, but associations at DRD2 and multiple genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses. Independent of genes expressed in brain, associations were enriched among genes expressed in tissues that play important roles in immunity, providing support for the hypothesized link between the immune system and schizophrenia.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Mapping genomic loci implicates genes and synaptic biology in schizophrenia

            Schizophrenia has a heritability of 60-80%1, much of which is attributable to common risk alleles. Here, in a two-stage genome-wide association study of up to 76,755 individuals with schizophrenia and 243,649 control individuals, we report common variant associations at 287 distinct genomic loci. Associations were concentrated in genes that are expressed in excitatory and inhibitory neurons of the central nervous system, but not in other tissues or cell types. Using fine-mapping and functional genomic data, we identify 120 genes (106 protein-coding) that are likely to underpin associations at some of these loci, including 16 genes with credible causal non-synonymous or untranslated region variation. We also implicate fundamental processes related to neuronal function, including synaptic organization, differentiation and transmission. Fine-mapped candidates were enriched for genes associated with rare disruptive coding variants in people with schizophrenia, including the glutamate receptor subunit GRIN2A and transcription factor SP4, and were also enriched for genes implicated by such variants in neurodevelopmental disorders. We identify biological processes relevant to schizophrenia pathophysiology; show convergence of common and rare variant associations in schizophrenia and neurodevelopmental disorders; and provide a resource of prioritized genes and variants to advance mechanistic studies.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.

              Schizophrenia is a severe mental disorder with a lifetime risk of about 1%, characterized by hallucinations, delusions and cognitive deficits, with heritability estimated at up to 80%. We performed a genome-wide association study of 3,322 European individuals with schizophrenia and 3,587 controls. Here we show, using two analytic approaches, the extent to which common genetic variation underlies the risk of schizophrenia. First, we implicate the major histocompatibility complex. Second, we provide molecular genetic evidence for a substantial polygenic component to the risk of schizophrenia involving thousands of common alleles of very small effect. We show that this component also contributes to the risk of bipolar disorder, but not to several non-psychiatric diseases.
                Bookmark

                Author and article information

                Contributors
                Marjan.Drukker@MaastrichtUniversity.nl
                Journal
                BMC Psychiatry
                BMC Psychiatry
                BMC Psychiatry
                BioMed Central (London )
                1471-244X
                26 October 2024
                26 October 2024
                2024
                : 24
                : 736
                Affiliations
                [1 ]Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience (MHeNS), Maastricht University Medical Centre, ( https://ror.org/02d9ce178) Maastricht, the Netherlands
                [2 ]Faculty of Health, Medicine and Life Sciences, Maastricht University, ( https://ror.org/02jz4aj89) Maastricht, The Netherlands
                [3 ]Department of Obstetrics and Gynecology, Ghent University Hospitals, Ghent University, ( https://ror.org/00cv9y106) Ghent, Belgium
                [4 ]GRID grid.5342.0, ISNI 0000 0001 2069 7798, Department of Neurology, , Ghent University Hospital, Ghent University, ; Ghent, Belgium
                [5 ]University Psychiatric Centre, Katholieke Universiteit Leuven, ( https://ror.org/05f950310) Kortenberg, Belgium
                [6 ]Department of Neurosciences, Centre for Clinical Psychiatry, Katholieke Universiteit Leuven, ( https://ror.org/05f950310) Louvain, Belgium
                [7 ]Leuven Brain Institute, Katholieke Universiteit Leuven, ( https://ror.org/05f950310) Louvain, Belgium
                [8 ]Antwerp Health, Law and Ethic Chair, University of Antwerp, ( https://ror.org/008x57b05) Antwerp, Belgium
                [9 ]Psychiatric Care Sint-Kamillus, Brothers of Charity, Bierbeek, Belgium
                [10 ]Department of Neurosciences, Research Group Psychiatry, Center for Clinical Psychiatry, Katholieke Universiteit Leuven, ( https://ror.org/05f950310) Louvain, Belgium
                [11 ]University Psychiatric Center, Katholieke Universiteit Leuven, ( https://ror.org/05f950310) Leuven, Belgium
                [12 ]GRID grid.36120.36, ISNI 0000 0004 0501 5439, Faculty of Psychology, , Open Universiteit, ; Heerlen, The Netherlands
                [13 ]GRID grid.47100.32, ISNI 0000000419368710, Department of Psychiatry, , Yale University School of Medicine, ; New Haven, CT USA
                [14 ]Department of Psychiatry, Brain Centre Rudolf Magnus, University Medical Centre Utrecht, ( https://ror.org/0575yy874) Utrecht, The Netherlands
                [15 ]GRID grid.467480.9, ISNI 0000 0004 0449 5311, Department of Psychosis Studies, Institute of Psychiatry, , King’s College London, King’s Health Partners, ; London, UK
                Author information
                http://orcid.org/0000-0002-6346-2662
                http://orcid.org/0009-0003-5520-7770
                Article
                6176
                10.1186/s12888-024-06176-2
                11515186
                39462331
                81407d70-aa4e-478f-ac4b-2234d431ef14
                © The Author(s) 2024

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 2 June 2023
                : 14 October 2024
                Categories
                Research
                Custom metadata
                © BioMed Central Ltd., part of Springer Nature 2024

                Clinical Psychology & Psychiatry
                aberrant salience,genetic vulnerability,subclinical psychotic symptoms

                Comments

                Comment on this article